Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents.

Cuneo A, Fagioli F, Pazzi I, Tallarico A, Previati R, Piva N, Carli MG, Balboni M, Castoldi G.

Leuk Res. 1992 Aug;16(8):789-96.

PMID:
1528067
2.

Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents.

Fagioli F, Cuneo A, Piva N, Carli MG, Previati R, Balboni M, Tomasi P, Cariani D, Scapoli G, Castoldi G.

Cancer. 1992 Jul 1;70(1):77-85.

3.

Chromosome aberrations in CD34-positive acute myeloid leukemia. Correlation with clinicopathologic features.

Fagioli F, Cuneo A, Carli MG, Bardi A, Piva N, Previati R, Rigolin GM, Ferrari L, Spanedda R, Castoldi G.

Cancer Genet Cytogenet. 1993 Dec;71(2):119-24.

PMID:
7506635
4.

Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.

Fruchart C, Lenormand B, Bastard C, Boulet D, Lesesve JF, Callat MP, Stamatoullas A, Monconduit M, Tilly H.

Am J Hematol. 1996 Nov;53(3):175-80.

5.

Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.

Davey FR, Abraham N Jr, Brunetto VL, MacCallum JM, Nelson DA, Ball ED, Griffin JD, Baer MR, Wurster-Hill D, Mayer RJ, et al.

Am J Hematol. 1995 May;49(1):29-38.

PMID:
7741135
6.

Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings.

Cuneo A, Ferrant A, Michaux JL, Boogaerts M, Demuynck H, Van Orshoven A, Criel A, Stul M, Dal Cin P, Hernandez J, et al.

Blood. 1995 Jun 15;85(12):3688-94.

7.

Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings.

Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N, Minotto C, Agostini P, De Angeli C, Del Senno L, Spanedda R, Castoldi G.

Br J Haematol. 1998 Oct;103(1):189-97.

PMID:
9792307
8.

Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.

Olopade OI, Thangavelu M, Larson RA, Mick R, Kowal-Vern A, Schumacher HR, Le Beau MM, Vardiman JW, Rowley JD.

Blood. 1992 Dec 1;80(11):2873-82.

9.

Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.

Larson RA, Le Beau MM.

Chem Biol Interact. 2005 May 30;153-154:187-95. Epub 2005 Apr 13.

PMID:
15935816
10.

3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features.

Testoni N, Borsaru G, Martinelli G, Carboni C, Ruggeri D, Ottaviani E, Pelliconi S, Ricci P, Pastano R, Visani G, Zaccaria A, Tura S.

Haematologica. 1999 Aug;84(8):690-4.

11.

Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers.

Cuneo A, Ferrant A, Michaux JL, Boogaerts M, Demuynck H, Bosly A, Doyen C, Carli MG, Piva N, Castoldi G, et al.

Leuk Lymphoma. 1993 Mar;9(4-5):285-91. Review.

PMID:
8348065
12.

Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia.

Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccola B.

Cancer Genet Cytogenet. 1981 Nov;4(3):197-214.

PMID:
7317873
13.

Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.

Nagai K, Kohno T, Chen YX, Tsushima H, Mori H, Nakamura H, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M, Bennett JM.

Leuk Res. 1996 Jul;20(7):563-74.

PMID:
8795690
14.

Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients.

Cuneo A, Mecucci C, Kerim S, Vandenberghe E, Dal Cin P, Van Orshoven A, Rodhain J, Bosly A, Michaux JL, Martiat P, et al.

Blood. 1989 Oct;74(5):1781-90.

15.

Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.

Blau O, Hofmann WK, Baldus CD, Thiel G, Serbent V, Schümann E, Thiel E, Blau IW.

Exp Hematol. 2007 Feb;35(2):221-9.

PMID:
17258071
16.

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA.

Blood. 2003 Jul 1;102(1):43-52. Epub 2003 Mar 6.

17.

Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukaemia.

Brozek I, Babińska M, Kardaś I, Woźniak A, Balcerska A, Hellmann A, Limon J.

J Appl Genet. 2003;44(3):401-12.

PMID:
12923315
18.

Cytogenetics and occupational exposure to solvents: a pilot study on leukemias and myelodysplastic disorders.

Vineis P, Avanzi GC, Giovinazzo B, Ponzio G, Cambrin GR, Ciccone G.

Tumori. 1990 Aug 31;76(4):350-2.

PMID:
2399564
19.

Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia.

Crane MM, Strom SS, Halabi S, Berman EL, Fueger JJ, Spitz MR, Keating MJ.

Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):639-44.

20.

Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.

Tamura S, Takemoto Y, Hashimoto-Tamaoki T, Mimura K, Sugahara Y, Senoh J, Furuyama JI, Kakishita E.

Int J Oncol. 1998 Jun;12(6):1259-62.

PMID:
9592183
Items per page

Supplemental Content

Write to the Help Desk